Literature DB >> 29850875

Neurologic disorders in 4858 survivors of central nervous system tumors in childhood-an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study.

Line Kenborg1, Jeanette Falck Winther1, Karen Markussen Linnet2, Anja Krøyer1, Vanna Albieri3, Anna Sällfors Holmqvist4, Laufey Tryggvadottir5,6, Laura Maria Madanat-Harjuoja7, Marilyn Stovall8, Henrik Hasle2, Jørgen H Olsen9.   

Abstract

Background: A comprehensive overview of neurologic complications among survivors of central nervous system (CNS) tumors in childhood is lacking. We aimed to investigate the risk for these disorders in a large, population-based study with outcome measures from nationwide hospital registries.
Methods: We identified 4858 five-year survivors with diagnoses of CNS tumor in childhood in Denmark, Iceland, Finland, and Sweden in 1943-2007, and 166658 matched population comparison subjects. Inpatient discharge diagnoses of neurologic disorders were used to calculate relative risks (RRs) and absolute excess risks (AERs).
Results: A neurologic disorder was verified in 1309 survivors, while 92.4 were expected, yielding an overall RR of 14.2 (95% confidence interval [CI]: 13.3-15.1) and an AER of 20 hospitalizations per 1000 persons per year. The risks remained increased more than 20 years after diagnosis (RR: 6.3, 95% CI: 5.6-7.2; AER: 11, 9-12). The most frequent diagnoses were epilepsy (affecting 14.1% of all survivors) followed by hydrocephalus (9.5%) and paralytic syndromes (4.2%), with RRs of 28.7 (95% CI: 26.0-31.6), 243 (95% CI: 190-311), and 40.3 (95% CI: 33.1-49.2), respectively. Of these outcomes, 30%-40% were diagnosed prior to or synchronously with the CNS tumor. The survivors had highly increased RRs for infectious diseases of the CNS, disorders of cranial nerves, and degenerative diseases of the nervous system. Conclusions: Survivors of childhood CNS tumors are at markedly increased risk for neurologic disorders throughout their lives. Health care professionals must be aware of survivors who might benefit from preventive interventions and intensive follow-up.

Entities:  

Year:  2019        PMID: 29850875      PMCID: PMC6303468          DOI: 10.1093/neuonc/noy094

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  33 in total

Review 1.  Prediction of cancer incidence in the Nordic countries up to the year 2020.

Authors:  Bjørn Møller; Harald Fekjaer; Timo Hakulinen; Laufey Tryggvadóttir; Hans H Storm; Mats Talbäck; Tor Haldorsen
Journal:  Eur J Cancer Prev       Date:  2002-06       Impact factor: 2.497

Review 2.  Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors.

Authors:  Daniel M Green; Larry E Kun; Katherine K Matthay; Anna T Meadows; William H Meyer; Paul A Meyers; Sheri L Spunt; Leslie L Robison; Melissa M Hudson
Journal:  Pediatr Blood Cancer       Date:  2013-02-15       Impact factor: 3.167

3.  Late and very late mortality in 5-year survivors of childhood cancer: changing pattern over four decades--experience from the Nordic countries.

Authors:  Stanislaw Garwicz; Harald Anderson; Jørgen H Olsen; Jeanette Falck Winther; Risto Sankila; Frøydis Langmark; Laufey Tryggvadóttir; Torgil R Möller
Journal:  Int J Cancer       Date:  2012-01-11       Impact factor: 7.396

4.  Evaluation of memory impairment in aging adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiotherapy.

Authors:  Gregory T Armstrong; Wilburn E Reddick; Ronald C Petersen; Aimee Santucci; Nan Zhang; Deokumar Srivastava; Robert J Ogg; Claudia M Hillenbrand; Noah Sabin; Matthew J Krasin; Larry Kun; Ching-Hon Pui; Melissa M Hudson; Leslie L Robison; Kevin R Krull
Journal:  J Natl Cancer Inst       Date:  2013-04-12       Impact factor: 13.506

Review 5.  Mild cognitive impairment as a diagnostic entity.

Authors:  R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

6.  Cardiovascular disease in Adult Life after Childhood Cancer in Scandinavia: A population-based cohort study of 32,308 one-year survivors.

Authors:  Thorgerdur Gudmundsdottir; Jeanette F Winther; Sofie de Fine Licht; Trine G Bonnesen; Peter H Asdahl; Laufey Tryggvadottir; Harald Anderson; Finn Wesenberg; Nea Malila; Henrik Hasle; Jørgen H Olsen
Journal:  Int J Cancer       Date:  2015-03-14       Impact factor: 7.396

Review 7.  Hydrocephalus in children.

Authors:  Kristopher T Kahle; Abhaya V Kulkarni; David D Limbrick; Benjamin C Warf
Journal:  Lancet       Date:  2015-08-06       Impact factor: 79.321

Review 8.  Late effects of therapy for pediatric brain tumor survivors.

Authors:  Christopher D Turner; Celiane Rey-Casserly; Cori C Liptak; Christine Chordas
Journal:  J Child Neurol       Date:  2009-11       Impact factor: 1.987

9.  Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors: a Childhood Cancer Survivor Study report.

Authors:  Elizabeth M Wells; Nicole J Ullrich; Kristy Seidel; Wendy Leisenring; Charles A Sklar; Gregory T Armstrong; Lisa Diller; Allison King; Kevin R Krull; Joseph P Neglia; Marilyn Stovall; Kimberly Whelan; Kevin C Oeffinger; Leslie L Robison; Roger J Packer
Journal:  Neuro Oncol       Date:  2018-01-10       Impact factor: 12.300

10.  Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study.

Authors:  Roger J Packer; James G Gurney; Judy A Punyko; Sarah S Donaldson; Peter D Inskip; Marilyn Stovall; Yutaka Yasui; Ann C Mertens; Charles A Sklar; H Stacy Nicholson; Lonnie K Zeltzer; Joseph P Neglia; Leslie L Robison
Journal:  J Clin Oncol       Date:  2003-09-01       Impact factor: 50.717

View more
  4 in total

1.  Tumor-related hydrocephalus in infants: a narrative review.

Authors:  Aaron M Yengo-Kahn; Michael C Dewan
Journal:  Childs Nerv Syst       Date:  2021-03-26       Impact factor: 1.475

2.  Multimorbidity patterns and risk of hospitalisation in children: A population cohort study of 3.6 million children in England, with illustrative examples from childhood cancer survivors.

Authors:  Sheng-Chia Chung; Stefanie Mueller; Katherine Green; Wai Hoong Chang; Darren Hargrave; Alvina G Lai
Journal:  Lancet Reg Health Eur       Date:  2022-06-30

3.  DNA methylation profiling improves routine diagnosis of paediatric central nervous system tumours: A prospective population-based study.

Authors:  Elizabeth Schepke; Maja Löfgren; Torsten Pietsch; Thomas Olsson Bontell; Teresia Kling; Anna Wenger; Sandra Ferreyra Vega; Anna Danielsson; Sandor Dosa; Stefan Holm; Anders Öberg; Per Nyman; Marie Eliasson-Hofvander; Per-Erik Sandström; Stefan M Pfister; Birgitta Lannering; Magnus Sabel; Helena Carén
Journal:  Neuropathol Appl Neurobiol       Date:  2022-08-03       Impact factor: 6.250

4.  Systematic Review: Sleep Disorders Based on Objective Data in Children and Adolescents Treated for a Brain Tumor.

Authors:  Anne Sophie Lind Helligsoe; Kathrine Synne Weile; Line Kenborg; Louise Tram Henriksen; Yasmin Lassen-Ramshad; Ali Amidi; Lisa Maria Wu; Jeanette Falck Winther; Line Pickering; René Mathiasen
Journal:  Front Neurosci       Date:  2022-02-22       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.